Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honghua Xiaoyao Pill versus oryzanol for perimenopausal syndrome
ChiCTR2100050783Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Honghua Xiaoyao Pill in climacteric (2 arms), sponsored by Tongji Hospital. Primary endpoint: Modified Kupperman Index. Started Jul 2021; status: recruiting.
02
Drugs
Honghua Xiaoyao Pill
03
Conditions
climacteric
Beyond the preview
Go deeper on ChiCTR2100050783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050783.